Talking abstract delivered by Dr Mark Arnold (Emory University School of Medicine, Atlanta, GA, USA) for the paper: Arnold M, Kuruvilla M and Levy JM. Management of Non-steroidal Anti-inflammatory Drug-exacerbated Respiratory Disease. touchREVIEWS in Respiratory & Pulmonary Diseases. 2021;6(1):21–5.
Management of Non-steroidal Anti-inflammatory Drug-exacerbated Respiratory Disease
Share
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Air pollution has been linked to exacerbating and causing symptoms associated with respiratory diseases, particularly impacting patients with asthma, COPD and allergic disease. touchRESPIRATORY were delighted to speak with Prof. Claudia Traidl-Hoffmann (University in Augsburg, Germany) around the symptoms associated with exposure to air pollution, the impact of air pollution on existing respiratory conditions and […]
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Dupilumab is used to manage chronic rhinosinusitis with nasal polyposis, however there is limited data regarding its use in patients with aspirin-exacerbated respiratory disease (AERD). touchRESPIRATORY caught up with Dr Isaac Schmale (University of Rochester Medical Center, Rochester, NY, USA) ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
touchRESPIRATORY were delighted to speak with Dr Isaac Schmale (University of Rochester Medical Center, Rochester, NY, USA) around the signs and symptoms of aspirin-exacerbated respiratory disease (AERD), the incidence of AERD in people with asthma, the current treatment paradigm for ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
NEW
Mepolizumab is currently approved for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) at a dose of 300mg. touchRESPIRATORY caught up with Dr. Ozge Can Bostan (Hacettepe University School of Medicine, Ankara, Turkey) to discuss the 1 year findings from her ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
It was a pleasure to talk with Dr Ronald Strauss (Cleveland Allergy and Asthma Center; Case Western Reserve University Medical School, Cleveland, OH, USA) around his article exploring the use of intranasal corticosteroids in the prevention and/ or treatment of ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
touchRESPIRATORY were delighted to talk with Dr Ronald Strauss (Cleveland Allergy and Asthma Center; Case Western Reserve University Medical School, Cleveland, OH, USA) around his analysis of the association of eosinophilia with improved COVID-19 outcomes in patients treated with inhaled ...
Mark CompleteCompleted
BookmarkBookmarked
TouchRESPIRATORY got the opportunity to catch up with Dr. David Fleischer (Children's Hospital Colorado, Aurora, CO, USA) to discuss the current available therapies and future of the treatment paradigm for peanut allergy. Questions How has the approval of Palforzia impacted ...
Mark CompleteCompleted
BookmarkBookmarked
touchRESPIRATORY joins Professor Frédéric de Blay (University Hospital of Strasbourg, Strasbourg, France) at EAACI 2021 to discuss the results of a phase 2, randomised, double-blind, placebo-controlled study of anti-Fel d 1 monoclonal antibodies in reducing the rate of early asthma responses, ...
Mark CompleteCompleted
BookmarkBookmarked
TouchRESPIRATORY got the opportunity to catch up with Dr Dermot Ryan (Asthma UK Centre for Applied Research, The University of Edinburgh, Edinburgh, Scotland) around his presentation on ‘Respiratory Allergy: The Role of Immunotherapy in Primary Care.' which was presented ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
